Abstract
Chagas disease is an endemic anthropozoonosis in 21 countries in the Americas with approximately 6 million people affected, whose etiological agent is the protozoan Trypanosoma cruzi (T. cruzi). After infection, the parasites initiate a metabolic reprogramming with the intention of accelerating intracellular multiplication, opting for a faster energy pathway to obtain ATP, the aerobic gly…